Oct 8, 2024 | Main Page Post, Product News, Rejuvenair
Underlying proof of rejuvenative healing indicative of airway remodeling corresponds with clinical efficacy and improved quality of life Boston, MA—Oct 8, 2024: /PRNewswire/ — CSA Medical, Inc., a leader in developing spray cryotherapy solutions for the...
Sep 16, 2024 | Main Page Post, Product News, Rejuvenair
Research reveals rejuvenative changes in cellular populations indicative of airway remodeling correspond with clinical efficacy and improved quality of life BOSTON, Sept. 16, 2024 /PRNewswire/ –CSA Medical, Inc., today announced multiple presentations at the...
Sep 9, 2024 | Main Page Post, Product News, Rejuvenair
TVM Capital Life Science and Yonjin Venture co-led the round, joined by a strong syndicate of existing investors BOSTON, Sept. 9, 2024 /PRNewswire/ — CSA Medical Inc., developer of The RejuvenAir® System, a Breakthrough Medical Device advancing the power of...
May 13, 2021 | Main Page Post, Product News, Rejuvenair, SPRAY-CB
These results should provide the scientific proof behind the remodeling response and clinical improvements identified in earlier studies Boston, MA—May 12, 2021: CSA Medical, Inc., today announced ® that all subjects have been enrolled in the RejuvenAir System study...
Apr 19, 2021 | Main Page Post, Product News, Rejuvenair, SPRAY-CB
Boston, MA –April 19, 2021: CSA Medical, Inc., today announced that Wissam Abouzgheib, MD, chief of pulmonary medicine at Cooper University Health Care, Camden, New Jersey, has joined the SPRAY-CB Study investigating a new device treatment for COPD with Chronic...
Nov 23, 2020 | Main Page Post, Product News, Rejuvenair
The RejuvenAir System is designed to address the underlying cause of COPD with Chronic Bronchitis and enable rejuvenative healing of the airways BOSTON, Nov. 23, 2020 — CSA Medical, Inc., today announced metered cryospray utilizing the RejuvenAir® System for the...
